Pharmanet Logo
|
  • Contact Us
  • |
  • RFP
  • | 
  • Media Center
  • |
  • Study Participants
  • |
  • Investigators
  • |
  • Français
    • Overview
    • History
    • Leadership Team
    • Executive Committee
    • Corporate Responsibility
    • Overview
    • Phase I-IIa
      • First-in-Man
        • Diverse Experience
        • Modern Facilities
        • Project Management
        • Rapid Recruitment
      • Proof-of-Concept
      • Bioavailability / Bioequivalence / Biosimilars
      • Drug Drug Interaction
      • QT/TQT Capabilities
      • Special Populations
    • Bioanalytical
      • Non-GLP Analysis
      • Method Development & Validation
      • Biomarkers
      • Large Molecule Analysis
      • Clinical Lab
      • Assay List
      • Instrumentation
    • Phase IIb-III
      • Biostatistics and Statistical Programming
      • Clinical Monitoring
      • Data Management
      • Feasibility Studies
      • Global Safety and Pharmacovigilance
      • Interactive Response Technologies
      • Investigator Recruitment and Site Management
      • Medical and Scientific Affairs
      • Medical Writing
      • Project Management
      • Patient Recruitment Services
        • Program Branding and Communications
        • Advertising and Promotion
        • Referral Network Management
      • Rater Training
    • Phase IV
      • Observational Research and Patient Registries
      • Interventional IIIB/IV Studies
      • Health Economics and Outcomes Research
      • Risk Management and Epidemiology
    • Quality Assurance
    • Consulting
      • 505(b)(2)
      • Biostatistics
      • Business Plan Services
      • Chemistry, Manufacturing, and Controls (CMC)
      • Clinical and Product Development
      • Global Safety and Pharmacovigilance
      • Pharmacokinetics and Pharmacodynamics (PK/PD)
      • Regulatory Services
    • Functional Service Providers
    • Staffing
    • Therapeutic Overview
    • Clinical Development Expertise
      • Biosimilars
      • Generics
      • Pediatrics
      • Small Molecule Therapeutics
    • Therapeutic Indications
      • Cardiovascular
      • Infectious Diseases/Vaccines
      • Neuroscience
      • Oncology
      • Pain
    • Overview
    • Asia Pacific
    • Europe
    • Latin America
    • North America
    • Overview
    • Articles
    • Brochures
    • Case Studies
    • Fact Sheets
    • PharmaNet Publications
    • Posters
    • Presentations
    • Videos/Podcasts/Webinars
    • White Papers
    • Overview
    • FAQ
    • Job Opportunities
    • Training Programs
    • Flexible Staffing
Print
this page
Email to
a Friend
Overview
Articles
Brochures
Case Studies
Fact Sheets
PharmaNet Publications
Posters
Presentations
Videos/Podcasts/Webinars
White Papers

Case Studies

Achieving Substantial Savings Through A PharmaNet/i3 Sourcing Partnership (116.08 KB)
Alzheimer’s Disease: Engaging patients, caregivers and investigators (144.83 KB)
Bridging Studies for 505 (b)(2) Approval (78.52 KB)
Clinical Training and Assessment Group Improves data Validity; Yields Only Positive Pivotal Study (51.66 KB)
H1N1 Vaccine Program (51.48 KB)
How PharmaNet/i3 met - and exceeded - a leading sponsor's metrics for global vaccine enrollment and DB lock (50.67 KB)
Meeting the challenges of a fragile, pediatric rare disease population (91.99 KB)
Non-Clinical and Regulatory Expertise Accelerates Development into Phase II-III Clinical Studies (59.25 KB)
Observational Study for Rheumatoid Arthritis (36.46 KB)
Pediatric Safety and Immunogenicity Evaluation of Meningococcal Vaccine (37.75 KB)
Renal Impairment Case Study (41.09 KB)
Safety Study for Rheumatoid Arthritis (36.26 KB)
Sourcing for Savings Case Study (223.67 KB)
The Benefit of Non-Clinical Scientific and Regulatory Support for Late Phase Studies (57.98 KB)

  • 504 Carnegie Center, Princeton, NJ 08540 USA
  • |
  • Phone: +1-609-951-6800
  • |
  • Email: pni@pharmanet-i3.com
  • |
  • Site Map
  • |
  • Privacy Policy
  • |
  • Terms & Conditions